Longitudinal Tumor Microenvironment Analysis in Extensive Stage SCLC Patients Treated with Dual Checkpoint Inhibitor Blockade

被引:0
|
作者
Chiang, A. [1 ]
Matera, R. [1 ]
Ashley, K. [2 ]
Rajendran, B. K. [2 ]
Schalper, K. A. [2 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Yale Univ, New Haven, CT USA
关键词
SCLC; Tumor Microenvironment; immunotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.13D.07
引用
收藏
页码:S362 / S362
页数:1
相关论文
共 50 条
  • [21] Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
    Ali, Omar Hasan
    Berner, Fiamma
    Ackermann, Christoph Jakob
    Ring, Sandra Stephanie
    Moulin, Alexandre
    Mueller, Joachim
    Markert, Eva
    Pop, Oltin Tiberiu
    Mueller, Stefanie
    Diem, Stefan
    Hundsberger, Thomas
    Flatz, Lukas
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (02) : 563 - 568
  • [22] Longitudinal microbiome-immune dynamics in melanoma patients treated with immune checkpoint inhibitor immunotherapy
    Simpson, Rebecca C.
    Shanahan, Erin R.
    Batten, Marcel
    Silva, Ines P.
    Reijers, Irene L.
    Versluis, Judith M.
    Menzies, Alexander M.
    Gonzalez, Maria
    Palendira, Umaimainthan
    Holmes, Andrew
    Wilmott, James S.
    Blank, Christian U.
    Scolyer, Richard A.
    Long, Georgina V.
    CANCER RESEARCH, 2023, 83 (07)
  • [23] Clinical Impact of Pre-Existing Autoantibodies in Patients With SCLC Treated With Immune Checkpoint Inhibitor: A Multicenter Prospective Observational Study
    Sato, Yuki
    Fujiwara, Satoru
    Hata, Akito
    Kida, Yoko
    Masuda, Takahiro
    Amimoto, Hisanori
    Matsumoto, Hirotaka
    Miyoshi, Kotoko
    Otsuka, Kojiro
    Tomii, Keisuke
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (12):
  • [24] Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade
    Zhang, Qu
    Luo, Jia
    Wu, Song
    Si, Han
    Gao, Chen
    Xu, Wenjing
    Abdullah, Shaad E.
    Higgs, Brandon W.
    Dennis, Phillip A.
    van der Heijden, Michiel S.
    Segal, Neil H.
    Chaft, Jamie E.
    Hembrough, Todd
    Barrett, J. Carl
    Hellmann, Matthew D.
    CANCER DISCOVERY, 2020, 10 (12) : 1842 - 1853
  • [25] Tumor volumetric analysis to correlate disease burden with response to dual immune checkpoint blockade in metastatic NSCLC
    Aminu, Muhammad
    Vokes, Natalie I.
    Saad, Maliazurina B.
    Li, Hui
    Hong, Lingzhi
    Mohamed, S. Mohamed
    Boom, John
    Chen, Pingjun
    Altan, Mehmet
    Gandhi, Saumil
    Swisher, Stephen
    Antonoff, Mara B.
    Pozadzides, Jenny V.
    Blumenschein, George, Jr.
    Gibbons, Don L.
    Cascone, Tina
    Elamin, Yasir Y.
    Le, Xiuning
    Negrao, Marcelo V.
    Skoulidis, Ferdinandos
    Tsao, Anne S.
    Tu, Janet
    Lee, J. Jack
    Zhang, Jianjun
    Heymach, John V.
    Wu, Jia
    CANCER RESEARCH, 2023, 83 (07)
  • [26] Efficacy and Safety of Anlotinib for Elderly Patients with Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions
    Song, Peng-Fei
    Xu, Ning
    Li, Qin
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 11133 - 11143
  • [27] Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer
    Gao, Yinjie
    Stein, Michelle M.
    Kase, Matthew
    Cummings, Amy L.
    Bharanikumar, Ramit
    Lau, Denise
    Garon, Edward B.
    Patel, Sandip P.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (02) : 339 - 350
  • [28] Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer
    Yinjie Gao
    Michelle M. Stein
    Matthew Kase
    Amy L. Cummings
    Ramit Bharanikumar
    Denise Lau
    Edward B. Garon
    Sandip P. Patel
    Cancer Immunology, Immunotherapy, 2023, 72 : 339 - 350
  • [29] Retrospective analysis of the management of extensive stage small cell lung cancer (SCLC) in patients with a poor performance status
    Moore, T.
    Gossage, L.
    Escola, C. Lopez
    Hennig, I.
    LUNG CANCER, 2019, 127 : S84 - S84
  • [30] Integrated Immunological Analysis of the Bone Marrow Tumor Microenvironment in Myeloproliferative Neoplasms to Determine Potential Efficacy of Immune Checkpoint Blockade
    Orlowski, Robert
    Huang, Alexander
    Gohil, Mercy
    Mangan, James
    Vignali, Marissa
    Emerson, Ryan O.
    Robins, Harlan
    Yusko, Erik
    Jordan, Martha S.
    Carroll, Martin
    Gilliland, D. Gary
    Hexner, Elizabeth O.
    BLOOD, 2015, 126 (23)